home > research channels > sectors > pharma


Latest News
04-Dec-2019 ‘Stop Sales by Unlicensed E-pharmacies’
27-Nov-2019 Pharma Inc Agrees to Cap Margins on Non-Price Control Drugs at 30%
19-Nov-2019 Glenmark Soars Over 21% On CLSA’s Upgrade
19-Nov-2019 Advent to Buy Majority Stake in Bharat Serums
18-Nov-2019 TA, Warburg Pincus & ChrysCap Shortlisted for 44% Stake in SRL
  more...
Latest Reports
Dec-19 Quick, early wins for Ayushman Bharat - IIFL  
Dec-19 FDA risk topping out; should start unwinding - IIFL  
Nov-19 Outperformance led by strong domestic growth - Centrum Research  
Nov-19 Strong domestic growth drives Q2 numbers... - ICICI direct.com  
Nov-19 Muted performance; regulatory overhang in focus - Edelweiss Securities  
  more...

Quarterly Summary September-2019
Desc Current Previous Per.Chg
Sales 14951.9 13120.7 14.0
Otherincome 734.4 802.5 -8.5
Expense 10741.5 10251.8 4.8
RawMaterial 4477.3 4246.8 5.4
StaffCost 2124.9 2044.3 3.9
ExciseDuty 0.0 0.0 -100.0
OtherExp 3181.4 3134.5 1.5
Interest 751.9 636.8 18.1
GrossProfit 4298.4 3104.6 38.5
Depreciation 825.8 752.0 9.8
Tax 22.3 506.0 -95.6
NetProfit 3907.4 1869.6 109.0
Total.Comp 42 -- --
Source: ETIG Database

Sectoral Companies As on 5 Dec 2019
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 104753.44
Divi's Lab 47823.47
Dr.Reddy's 47684.67
Cipla 37248.75
Lupin 35296.39
Biocon 34422.00
Piramal Entp 33918.42
Torrent Phar 31713.52
GlaxoSmith.P 27863.71
Abbott (I) 27159.09
Cadila Healt 26411.46
Aurobindo Ph 26321.56
Alkem Labora 25032.57
  click here for the complete list